Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

New understanding and treatments for hair loss are improving, but more research is needed.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Understanding hair health and disorders is important for effective treatment.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Future hair cosmetics will be safer and more effective.

A gene deletion in DSG4 causes sparse hair in some Pakistani families.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Erlotinib can cause persistent excessive hair growth.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

Bee venom, fig, and geranium oil can effectively treat skin conditions and are safer alternatives to some conventional drugs.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

A specific gene mutation causes severe skin and nail issues and hair loss.

Mutations in the DSG4 gene cause fragile, sparse hair in humans, mice, and rats.

Nanocosmetics with natural extracts offer benefits but need more research on safety and environmental impact.

Nanofat shows promise for facial rejuvenation and treating skin issues but needs more research for long-term safety.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Humans heal wounds slower than non-human primates and rodents.

Scalp allergic reactions are often missed, needing specific tests and avoiding certain hair products for proper treatment.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

High-frequency ultrasonography helps diagnose and manage hair and nail disorders safely and effectively.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Sports influence skin condition names and help in diagnosis and treatment.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Afro-textured hair needs personalized care due to its unique genetic traits.